Bangladesh's New Measles Crisis

New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions

Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content: * A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026 [https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.7591?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Why Exercise Still Matters in the GLP-1 Drug Era

JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: * In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA [https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.11338?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

The Search for a Fentanyl Vaccine

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content: * Inside the Push for a Fentanyl Vaccine [https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.6392?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

New Insights on HFpEF in Patients With Severe Obesity

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content: * HFpEF May Be a Different Disease in Patients With Severe Obesity [https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.7580?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Is There a Doctor on the Ship?

Joining from quarantine, Stephen Kornfeld, MD, discusses his experience stepping in as the ship's physician when hantavirus transformed his vacation cruise into a global public health concern. Related Content: * Hantavirus Outbreak: First Test of US Public Health Response After WHO Withdrawal [https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.9419?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * When Hantavirus Sickened the Ship's Physician, Stephen Kornfeld, MD, Stepped Up [https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.10380?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]